JP4551219B2 - ＬｂＬコーティングを医療用デバイスに適用する方法 - Google Patents
ＬｂＬコーティングを医療用デバイスに適用する方法 Download PDFInfo
- Publication number
- JP4551219B2 JP4551219B2 JP2004535481A JP2004535481A JP4551219B2 JP 4551219 B2 JP4551219 B2 JP 4551219B2 JP 2004535481 A JP2004535481 A JP 2004535481A JP 2004535481 A JP2004535481 A JP 2004535481A JP 4551219 B2 JP4551219 B2 JP 4551219B2
- Authority
- JP
- Japan
- Prior art keywords
- medical device
- polyionic material
- coating
- solution
- polyionic
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 238000000576 coating method Methods 0.000 title claims abstract description 130
- 239000011248 coating agent Substances 0.000 title claims abstract description 117
- 238000000034 method Methods 0.000 title claims abstract description 49
- 239000000463 material Substances 0.000 claims abstract description 162
- 230000008569 process Effects 0.000 claims abstract description 7
- 239000000243 solution Substances 0.000 claims description 113
- 229920000831 ionic polymer Polymers 0.000 claims description 110
- 229920002125 Sokalan® Polymers 0.000 claims description 75
- 229920000867 polyelectrolyte Polymers 0.000 claims description 32
- -1 aminoalkyl polysaccharides Chemical class 0.000 claims description 24
- 238000005507 spraying Methods 0.000 claims description 16
- 229920001282 polysaccharide Polymers 0.000 claims description 6
- 239000005017 polysaccharide Substances 0.000 claims description 6
- 150000004676 glycans Chemical class 0.000 claims description 5
- 229920000962 poly(amidoamine) Polymers 0.000 claims description 5
- 239000012487 rinsing solution Substances 0.000 claims description 4
- FHVDTGUDJYJELY-UHFFFAOYSA-N 6-{[2-carboxy-4,5-dihydroxy-6-(phosphanyloxy)oxan-3-yl]oxy}-4,5-dihydroxy-3-phosphanyloxane-2-carboxylic acid Chemical compound O1C(C(O)=O)C(P)C(O)C(O)C1OC1C(C(O)=O)OC(OP)C(O)C1O FHVDTGUDJYJELY-UHFFFAOYSA-N 0.000 claims description 3
- 229920002134 Carboxymethyl cellulose Polymers 0.000 claims description 3
- 229920001661 Chitosan Polymers 0.000 claims description 3
- 229920000855 Fucoidan Polymers 0.000 claims description 3
- 229920002148 Gellan gum Polymers 0.000 claims description 3
- 102000003886 Glycoproteins Human genes 0.000 claims description 3
- 108090000288 Glycoproteins Proteins 0.000 claims description 3
- 229920002683 Glycosaminoglycan Polymers 0.000 claims description 3
- 229920000805 Polyaspartic acid Polymers 0.000 claims description 3
- 108010020346 Polyglutamic Acid Proteins 0.000 claims description 3
- 229940072056 alginate Drugs 0.000 claims description 3
- 229920000615 alginic acid Polymers 0.000 claims description 3
- 235000010443 alginic acid Nutrition 0.000 claims description 3
- 239000001768 carboxy methyl cellulose Substances 0.000 claims description 3
- 235000010948 carboxy methyl cellulose Nutrition 0.000 claims description 3
- 239000008112 carboxymethyl-cellulose Substances 0.000 claims description 3
- 239000001814 pectin Substances 0.000 claims description 3
- 229920001277 pectin Polymers 0.000 claims description 3
- 235000010987 pectin Nutrition 0.000 claims description 3
- 108010064470 polyaspartate Proteins 0.000 claims description 3
- 229920002643 polyglutamic acid Polymers 0.000 claims description 3
- 229920002101 Chitin Polymers 0.000 claims description 2
- 125000004181 carboxyalkyl group Chemical group 0.000 claims description 2
- 125000002057 carboxymethyl group Chemical group [H]OC(=O)C([H])([H])[*] 0.000 claims description 2
- SENLDUJVTGGYIH-UHFFFAOYSA-N n-(2-aminoethyl)-3-[[3-(2-aminoethylamino)-3-oxopropyl]-[2-[bis[3-(2-aminoethylamino)-3-oxopropyl]amino]ethyl]amino]propanamide Chemical compound NCCNC(=O)CCN(CCC(=O)NCCN)CCN(CCC(=O)NCCN)CCC(=O)NCCN SENLDUJVTGGYIH-UHFFFAOYSA-N 0.000 claims description 2
- 239000010410 layer Substances 0.000 claims 9
- 229920002307 Dextran Polymers 0.000 claims 1
- 239000002356 single layer Substances 0.000 claims 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 abstract description 7
- 229910052760 oxygen Inorganic materials 0.000 abstract description 7
- 239000001301 oxygen Substances 0.000 abstract description 7
- 230000001965 increasing effect Effects 0.000 abstract description 6
- 230000035699 permeability Effects 0.000 abstract description 5
- 230000010220 ion permeability Effects 0.000 abstract description 3
- 239000004584 polyacrylic acid Substances 0.000 description 68
- 229920002518 Polyallylamine hydrochloride Polymers 0.000 description 46
- 239000000758 substrate Substances 0.000 description 17
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 17
- 229920000642 polymer Polymers 0.000 description 16
- 229920001577 copolymer Polymers 0.000 description 12
- 239000011162 core material Substances 0.000 description 11
- LOKCTEFSRHRXRJ-UHFFFAOYSA-I dipotassium trisodium dihydrogen phosphate hydrogen phosphate dichloride Chemical compound P(=O)(O)(O)[O-].[K+].P(=O)(O)([O-])[O-].[Na+].[Na+].[Cl-].[K+].[Cl-].[Na+] LOKCTEFSRHRXRJ-UHFFFAOYSA-I 0.000 description 11
- 239000002953 phosphate buffered saline Substances 0.000 description 11
- 150000003839 salts Chemical class 0.000 description 10
- 210000004369 blood Anatomy 0.000 description 9
- 239000008280 blood Substances 0.000 description 9
- 229910052757 nitrogen Inorganic materials 0.000 description 9
- 239000000017 hydrogel Substances 0.000 description 8
- 238000005259 measurement Methods 0.000 description 8
- 239000000654 additive Substances 0.000 description 7
- 229920001222 biopolymer Polymers 0.000 description 7
- 238000007654 immersion Methods 0.000 description 7
- 229920001296 polysiloxane Polymers 0.000 description 7
- SMZOUWXMTYCWNB-UHFFFAOYSA-N 2-(2-methoxy-5-methylphenyl)ethanamine Chemical compound COC1=CC=C(C)C=C1CCN SMZOUWXMTYCWNB-UHFFFAOYSA-N 0.000 description 6
- 239000000178 monomer Substances 0.000 description 6
- 229920000083 poly(allylamine) Polymers 0.000 description 6
- 229920002851 polycationic polymer Polymers 0.000 description 6
- NIXOWILDQLNWCW-UHFFFAOYSA-N 2-Propenoic acid Natural products OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 5
- 238000012512 characterization method Methods 0.000 description 5
- 239000011521 glass Substances 0.000 description 5
- 230000002209 hydrophobic effect Effects 0.000 description 5
- 230000004048 modification Effects 0.000 description 5
- 238000012986 modification Methods 0.000 description 5
- 229920000447 polyanionic polymer Polymers 0.000 description 5
- 239000002861 polymer material Substances 0.000 description 5
- 239000002904 solvent Substances 0.000 description 5
- 239000007921 spray Substances 0.000 description 5
- 238000004381 surface treatment Methods 0.000 description 5
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 4
- 229920002845 Poly(methacrylic acid) Polymers 0.000 description 4
- 229920002873 Polyethylenimine Polymers 0.000 description 4
- 210000004204 blood vessel Anatomy 0.000 description 4
- 238000007598 dipping method Methods 0.000 description 4
- 229920001519 homopolymer Polymers 0.000 description 4
- 239000000203 mixture Substances 0.000 description 4
- 239000003607 modifier Substances 0.000 description 4
- 102000004169 proteins and genes Human genes 0.000 description 4
- 108090000623 proteins and genes Proteins 0.000 description 4
- 239000000126 substance Substances 0.000 description 4
- 238000012360 testing method Methods 0.000 description 4
- 210000001519 tissue Anatomy 0.000 description 4
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 3
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 3
- CERQOIWHTDAKMF-UHFFFAOYSA-N Methacrylic acid Chemical compound CC(=C)C(O)=O CERQOIWHTDAKMF-UHFFFAOYSA-N 0.000 description 3
- WHNWPMSKXPGLAX-UHFFFAOYSA-N N-Vinyl-2-pyrrolidone Chemical compound C=CN1CCCC1=O WHNWPMSKXPGLAX-UHFFFAOYSA-N 0.000 description 3
- 239000004721 Polyphenylene oxide Substances 0.000 description 3
- 239000004809 Teflon Substances 0.000 description 3
- 229920006362 Teflon® Polymers 0.000 description 3
- 230000001133 acceleration Effects 0.000 description 3
- 230000000996 additive effect Effects 0.000 description 3
- 230000000845 anti-microbial effect Effects 0.000 description 3
- 238000000889 atomisation Methods 0.000 description 3
- 150000001720 carbohydrates Chemical class 0.000 description 3
- 230000010261 cell growth Effects 0.000 description 3
- 230000008859 change Effects 0.000 description 3
- 150000001875 compounds Chemical class 0.000 description 3
- 210000004087 cornea Anatomy 0.000 description 3
- 238000000151 deposition Methods 0.000 description 3
- 238000003618 dip coating Methods 0.000 description 3
- 238000009826 distribution Methods 0.000 description 3
- 239000007789 gas Substances 0.000 description 3
- 125000004356 hydroxy functional group Chemical group O* 0.000 description 3
- 150000002632 lipids Chemical class 0.000 description 3
- 239000000314 lubricant Substances 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 125000005010 perfluoroalkyl group Chemical group 0.000 description 3
- 229920000570 polyether Polymers 0.000 description 3
- 125000001424 substituent group Chemical group 0.000 description 3
- BFKJFAAPBSQJPD-UHFFFAOYSA-N tetrafluoroethene Chemical group FC(F)=C(F)F BFKJFAAPBSQJPD-UHFFFAOYSA-N 0.000 description 3
- 229920002554 vinyl polymer Polymers 0.000 description 3
- YSYRISKCBOPJRG-UHFFFAOYSA-N 4,5-difluoro-2,2-bis(trifluoromethyl)-1,3-dioxole Chemical compound FC1=C(F)OC(C(F)(F)F)(C(F)(F)F)O1 YSYRISKCBOPJRG-UHFFFAOYSA-N 0.000 description 2
- HRPVXLWXLXDGHG-UHFFFAOYSA-N Acrylamide Chemical compound NC(=O)C=C HRPVXLWXLXDGHG-UHFFFAOYSA-N 0.000 description 2
- 229920002126 Acrylic acid copolymer Polymers 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- 238000012935 Averaging Methods 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 2
- 229920000388 Polyphosphate Polymers 0.000 description 2
- 229910000831 Steel Inorganic materials 0.000 description 2
- PPBRXRYQALVLMV-UHFFFAOYSA-N Styrene Chemical compound C=CC1=CC=CC=C1 PPBRXRYQALVLMV-UHFFFAOYSA-N 0.000 description 2
- 125000001931 aliphatic group Chemical group 0.000 description 2
- 125000002947 alkylene group Chemical group 0.000 description 2
- 150000003868 ammonium compounds Chemical group 0.000 description 2
- 229920006318 anionic polymer Polymers 0.000 description 2
- 239000004599 antimicrobial Substances 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 230000004397 blinking Effects 0.000 description 2
- 210000001124 body fluid Anatomy 0.000 description 2
- 150000001735 carboxylic acids Chemical class 0.000 description 2
- 239000000919 ceramic Substances 0.000 description 2
- 239000000975 dye Substances 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 210000000981 epithelium Anatomy 0.000 description 2
- 239000000835 fiber Substances 0.000 description 2
- 239000012530 fluid Substances 0.000 description 2
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 2
- 239000010931 gold Substances 0.000 description 2
- 229910052737 gold Inorganic materials 0.000 description 2
- 230000036541 health Effects 0.000 description 2
- ZSIAUFGUXNUGDI-UHFFFAOYSA-N hexan-1-ol Chemical compound CCCCCCO ZSIAUFGUXNUGDI-UHFFFAOYSA-N 0.000 description 2
- 230000005660 hydrophilic surface Effects 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 239000012528 membrane Substances 0.000 description 2
- FQPSGWSUVKBHSU-UHFFFAOYSA-N methacrylamide Chemical compound CC(=C)C(N)=O FQPSGWSUVKBHSU-UHFFFAOYSA-N 0.000 description 2
- 229940088644 n,n-dimethylacrylamide Drugs 0.000 description 2
- YLGYACDQVQQZSW-UHFFFAOYSA-N n,n-dimethylprop-2-enamide Chemical compound CN(C)C(=O)C=C YLGYACDQVQQZSW-UHFFFAOYSA-N 0.000 description 2
- 229920002939 poly(N,N-dimethylacrylamides) Polymers 0.000 description 2
- 229920000172 poly(styrenesulfonic acid) Polymers 0.000 description 2
- 229920002401 polyacrylamide Polymers 0.000 description 2
- 229920000058 polyacrylate Polymers 0.000 description 2
- 230000000379 polymerizing effect Effects 0.000 description 2
- 229920000193 polymethacrylate Polymers 0.000 description 2
- 239000001205 polyphosphate Substances 0.000 description 2
- 235000011176 polyphosphates Nutrition 0.000 description 2
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 2
- 239000010453 quartz Substances 0.000 description 2
- 125000000467 secondary amino group Chemical group [H]N([*:1])[*:2] 0.000 description 2
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N silicon dioxide Inorganic materials O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 2
- 239000010959 steel Substances 0.000 description 2
- 238000003860 storage Methods 0.000 description 2
- 229920001059 synthetic polymer Polymers 0.000 description 2
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 2
- KZNXWXJWASHRAV-UHFFFAOYSA-M (2-hydroxy-5-methyl-4-oxohex-5-enyl)-trimethylazanium;chloride Chemical compound [Cl-].CC(=C)C(=O)CC(O)C[N+](C)(C)C KZNXWXJWASHRAV-UHFFFAOYSA-M 0.000 description 1
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 description 1
- XFNJYAKDBJUJAJ-UHFFFAOYSA-N 1,2-dibromopropane Chemical compound CC(Br)CBr XFNJYAKDBJUJAJ-UHFFFAOYSA-N 0.000 description 1
- KNKRKFALVUDBJE-UHFFFAOYSA-N 1,2-dichloropropane Chemical compound CC(Cl)CCl KNKRKFALVUDBJE-UHFFFAOYSA-N 0.000 description 1
- ABADUMLIAZCWJD-UHFFFAOYSA-N 1,3-dioxole Chemical class C1OC=CO1 ABADUMLIAZCWJD-UHFFFAOYSA-N 0.000 description 1
- RBZMSGOBSOCYHR-UHFFFAOYSA-N 1,4-bis(bromomethyl)benzene Chemical compound BrCC1=CC=C(CBr)C=C1 RBZMSGOBSOCYHR-UHFFFAOYSA-N 0.000 description 1
- ZZHIDJWUJRKHGX-UHFFFAOYSA-N 1,4-bis(chloromethyl)benzene Chemical compound ClCC1=CC=C(CCl)C=C1 ZZHIDJWUJRKHGX-UHFFFAOYSA-N 0.000 description 1
- DZSVIVLGBJKQAP-UHFFFAOYSA-N 1-(2-methyl-5-propan-2-ylcyclohex-2-en-1-yl)propan-1-one Chemical compound CCC(=O)C1CC(C(C)C)CC=C1C DZSVIVLGBJKQAP-UHFFFAOYSA-N 0.000 description 1
- KGIGUEBEKRSTEW-UHFFFAOYSA-N 2-vinylpyridine Chemical compound C=CC1=CC=CC=N1 KGIGUEBEKRSTEW-UHFFFAOYSA-N 0.000 description 1
- XKTYXVDYIKIYJP-UHFFFAOYSA-N 3h-dioxole Chemical compound C1OOC=C1 XKTYXVDYIKIYJP-UHFFFAOYSA-N 0.000 description 1
- SQDAZGGFXASXDW-UHFFFAOYSA-N 5-bromo-2-(trifluoromethoxy)pyridine Chemical compound FC(F)(F)OC1=CC=C(Br)C=N1 SQDAZGGFXASXDW-UHFFFAOYSA-N 0.000 description 1
- NLHHRLWOUZZQLW-UHFFFAOYSA-N Acrylonitrile Chemical compound C=CC#N NLHHRLWOUZZQLW-UHFFFAOYSA-N 0.000 description 1
- 102000009027 Albumins Human genes 0.000 description 1
- 108010088751 Albumins Proteins 0.000 description 1
- 229920001287 Chondroitin sulfate Polymers 0.000 description 1
- 241000284156 Clerodendrum quadriloculare Species 0.000 description 1
- 102000008186 Collagen Human genes 0.000 description 1
- 108010035532 Collagen Proteins 0.000 description 1
- 229920004934 Dacron® Polymers 0.000 description 1
- VZCYOOQTPOCHFL-OWOJBTEDSA-N Fumaric acid Natural products OC(=O)\C=C\C(O)=O VZCYOOQTPOCHFL-OWOJBTEDSA-N 0.000 description 1
- 229920002971 Heparan sulfate Polymers 0.000 description 1
- HTTJABKRGRZYRN-UHFFFAOYSA-N Heparin Chemical compound OC1C(NC(=O)C)C(O)OC(COS(O)(=O)=O)C1OC1C(OS(O)(=O)=O)C(O)C(OC2C(C(OS(O)(=O)=O)C(OC3C(C(O)C(O)C(O3)C(O)=O)OS(O)(=O)=O)C(CO)O2)NS(O)(=O)=O)C(C(O)=O)O1 HTTJABKRGRZYRN-UHFFFAOYSA-N 0.000 description 1
- 229920000271 Kevlar® Polymers 0.000 description 1
- 239000004472 Lysine Substances 0.000 description 1
- CERQOIWHTDAKMF-UHFFFAOYSA-M Methacrylate Chemical compound CC(=C)C([O-])=O CERQOIWHTDAKMF-UHFFFAOYSA-M 0.000 description 1
- 239000004677 Nylon Substances 0.000 description 1
- 206010052143 Ocular discomfort Diseases 0.000 description 1
- OFOBLEOULBTSOW-UHFFFAOYSA-N Propanedioic acid Natural products OC(=O)CC(O)=O OFOBLEOULBTSOW-UHFFFAOYSA-N 0.000 description 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 229920006322 acrylamide copolymer Polymers 0.000 description 1
- 150000003926 acrylamides Chemical class 0.000 description 1
- 150000001252 acrylic acid derivatives Chemical class 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 239000005456 alcohol based solvent Substances 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 150000001335 aliphatic alkanes Chemical class 0.000 description 1
- 125000005907 alkyl ester group Chemical group 0.000 description 1
- 125000000217 alkyl group Chemical group 0.000 description 1
- 230000004075 alteration Effects 0.000 description 1
- 150000001412 amines Chemical class 0.000 description 1
- 125000003277 amino group Chemical group 0.000 description 1
- 150000001450 anions Chemical class 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 239000002473 artificial blood Substances 0.000 description 1
- XFOZBWSTIQRFQW-UHFFFAOYSA-M benzyl-dimethyl-prop-2-enylazanium;chloride Chemical compound [Cl-].C=CC[N+](C)(C)CC1=CC=CC=C1 XFOZBWSTIQRFQW-UHFFFAOYSA-M 0.000 description 1
- 239000012620 biological material Substances 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- 239000013590 bulk material Substances 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 1
- 125000003636 chemical group Chemical group 0.000 description 1
- 229940059329 chondroitin sulfate Drugs 0.000 description 1
- 229920001436 collagen Polymers 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 238000004040 coloring Methods 0.000 description 1
- 239000002131 composite material Substances 0.000 description 1
- 229920001940 conductive polymer Polymers 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 238000012937 correction Methods 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 230000032798 delamination Effects 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- XLYOFNOQVPJJNP-DYCDLGHISA-N deuterium hydrogen oxide Chemical group [2H]O XLYOFNOQVPJJNP-DYCDLGHISA-N 0.000 description 1
- 238000000502 dialysis Methods 0.000 description 1
- 150000004985 diamines Chemical class 0.000 description 1
- 239000004205 dimethyl polysiloxane Substances 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 238000012377 drug delivery Methods 0.000 description 1
- 125000000816 ethylene group Chemical group [H]C([H])([*:1])C([H])([H])[*:2] 0.000 description 1
- 210000000744 eyelid Anatomy 0.000 description 1
- 229920002313 fluoropolymer Polymers 0.000 description 1
- 239000001530 fumaric acid Substances 0.000 description 1
- 125000000524 functional group Chemical group 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 239000003966 growth inhibitor Substances 0.000 description 1
- IXCSERBJSXMMFS-UHFFFAOYSA-N hcl hcl Chemical compound Cl.Cl IXCSERBJSXMMFS-UHFFFAOYSA-N 0.000 description 1
- 210000003128 head Anatomy 0.000 description 1
- 210000003709 heart valve Anatomy 0.000 description 1
- 229960002897 heparin Drugs 0.000 description 1
- 229920002674 hyaluronan Polymers 0.000 description 1
- 229960003160 hyaluronic acid Drugs 0.000 description 1
- 150000003840 hydrochlorides Chemical class 0.000 description 1
- 239000012433 hydrogen halide Substances 0.000 description 1
- 229910000039 hydrogen halide Inorganic materials 0.000 description 1
- 230000002706 hydrostatic effect Effects 0.000 description 1
- 239000007943 implant Substances 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 239000011261 inert gas Substances 0.000 description 1
- 239000011147 inorganic material Substances 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 150000002605 large molecules Chemical class 0.000 description 1
- VZCYOOQTPOCHFL-UPHRSURJSA-N maleic acid Chemical compound OC(=O)\C=C/C(O)=O VZCYOOQTPOCHFL-UPHRSURJSA-N 0.000 description 1
- 239000011976 maleic acid Substances 0.000 description 1
- 150000002734 metacrylic acid derivatives Chemical class 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000007769 metal material Substances 0.000 description 1
- 229920003145 methacrylic acid copolymer Polymers 0.000 description 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
- 239000003595 mist Substances 0.000 description 1
- 238000012544 monitoring process Methods 0.000 description 1
- 125000000740 n-pentyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 230000009871 nonspecific binding Effects 0.000 description 1
- 229920001778 nylon Polymers 0.000 description 1
- 229940054534 ophthalmic solution Drugs 0.000 description 1
- 239000002997 ophthalmic solution Substances 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 229920000620 organic polymer Polymers 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 239000010702 perfluoropolyether Substances 0.000 description 1
- 125000001476 phosphono group Chemical group [H]OP(*)(=O)O[H] 0.000 description 1
- 238000005289 physical deposition Methods 0.000 description 1
- 238000009832 plasma treatment Methods 0.000 description 1
- 229920000765 poly(2-oxazolines) Polymers 0.000 description 1
- 229920005575 poly(amic acid) Polymers 0.000 description 1
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 description 1
- 229920002246 poly[2-(dimethylamino)ethyl methacrylate] polymer Polymers 0.000 description 1
- 239000005020 polyethylene terephthalate Substances 0.000 description 1
- 229920002338 polyhydroxyethylmethacrylate Polymers 0.000 description 1
- 239000005518 polymer electrolyte Substances 0.000 description 1
- 229920000307 polymer substrate Polymers 0.000 description 1
- 238000006116 polymerization reaction Methods 0.000 description 1
- 229920000098 polyolefin Polymers 0.000 description 1
- 229920001343 polytetrafluoroethylene Polymers 0.000 description 1
- 239000004810 polytetrafluoroethylene Substances 0.000 description 1
- 229920002635 polyurethane Polymers 0.000 description 1
- 239000004814 polyurethane Substances 0.000 description 1
- 229920002689 polyvinyl acetate Polymers 0.000 description 1
- 239000011118 polyvinyl acetate Substances 0.000 description 1
- 229920000915 polyvinyl chloride Polymers 0.000 description 1
- 239000004800 polyvinyl chloride Substances 0.000 description 1
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 1
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 1
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- QQONPFPTGQHPMA-UHFFFAOYSA-N propylene Natural products CC=C QQONPFPTGQHPMA-UHFFFAOYSA-N 0.000 description 1
- 125000004805 propylene group Chemical group [H]C([H])([H])C([H])([*:1])C([H])([H])[*:2] 0.000 description 1
- 125000001453 quaternary ammonium group Chemical group 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 230000008439 repair process Effects 0.000 description 1
- 229920000260 silastic Polymers 0.000 description 1
- 239000010703 silicon Substances 0.000 description 1
- 229910052710 silicon Inorganic materials 0.000 description 1
- 150000003384 small molecules Chemical class 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 230000003068 static effect Effects 0.000 description 1
- 150000003440 styrenes Chemical class 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 125000001302 tertiary amino group Chemical group 0.000 description 1
- 229910021642 ultra pure water Inorganic materials 0.000 description 1
- 239000012498 ultrapure water Substances 0.000 description 1
- 125000000391 vinyl group Chemical group [H]C([*])=C([H])[H] 0.000 description 1
- 230000029663 wound healing Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/28—Materials for coating prostheses
- A61L27/34—Macromolecular materials
-
- G—PHYSICS
- G02—OPTICS
- G02B—OPTICAL ELEMENTS, SYSTEMS OR APPARATUS
- G02B1/00—Optical elements characterised by the material of which they are made; Optical coatings for optical elements
- G02B1/04—Optical elements characterised by the material of which they are made; Optical coatings for optical elements made of organic materials, e.g. plastics
- G02B1/041—Lenses
- G02B1/043—Contact lenses
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B05—SPRAYING OR ATOMISING IN GENERAL; APPLYING FLUENT MATERIALS TO SURFACES, IN GENERAL
- B05D—PROCESSES FOR APPLYING FLUENT MATERIALS TO SURFACES, IN GENERAL
- B05D1/00—Processes for applying liquids or other fluent materials
- B05D1/18—Processes for applying liquids or other fluent materials performed by dipping
- B05D1/185—Processes for applying liquids or other fluent materials performed by dipping applying monomolecular layers
Landscapes
- Health & Medical Sciences (AREA)
- Physics & Mathematics (AREA)
- Oral & Maxillofacial Surgery (AREA)
- General Health & Medical Sciences (AREA)
- Dermatology (AREA)
- Transplantation (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- General Physics & Mathematics (AREA)
- Optics & Photonics (AREA)
- Materials For Medical Uses (AREA)
- Eyeglasses (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US40994502P | 2002-09-11 | 2002-09-11 | |
| PCT/EP2003/010065 WO2004025332A1 (en) | 2002-09-11 | 2003-09-10 | Method for applying an lbl coating onto a medical device |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2005538418A JP2005538418A (ja) | 2005-12-15 |
| JP2005538418A5 JP2005538418A5 (enExample) | 2006-10-26 |
| JP4551219B2 true JP4551219B2 (ja) | 2010-09-22 |
Family
ID=31994035
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2004535481A Expired - Lifetime JP4551219B2 (ja) | 2002-09-11 | 2003-09-10 | ＬｂＬコーティングを医療用デバイスに適用する方法 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US6896926B2 (enExample) |
| EP (1) | EP1540381B1 (enExample) |
| JP (1) | JP4551219B2 (enExample) |
| AT (1) | ATE353141T1 (enExample) |
| AU (1) | AU2003273851A1 (enExample) |
| DE (1) | DE60311584T2 (enExample) |
| WO (1) | WO2004025332A1 (enExample) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2022224717A1 (ja) | 2021-04-19 | 2022-10-27 | 国立研究開発法人物質・材料研究機構 | 軟質眼用レンズ及びその製造方法 |
Families Citing this family (158)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6159232A (en) | 1997-12-16 | 2000-12-12 | Closys Corporation | Clotting cascade initiating apparatus and methods of use and methods of closing wounds |
| US6478808B2 (en) | 1997-12-17 | 2002-11-12 | Closys Corporation | Clotting cascade initiating apparatus and methods of use and methods of closing wounds |
| US6451871B1 (en) | 1998-11-25 | 2002-09-17 | Novartis Ag | Methods of modifying surface characteristics |
| US20030069601A1 (en) * | 1998-12-15 | 2003-04-10 | Closys Corporation | Clotting cascade initiating apparatus and methods of use |
| AR027348A1 (es) * | 2000-02-04 | 2003-03-26 | Novartis Ag | Proceso para recubrir una superficie |
| WO2003002243A2 (en) | 2001-06-27 | 2003-01-09 | Remon Medical Technologies Ltd. | Method and device for electrochemical formation of therapeutic species in vivo |
| US20080026068A1 (en) * | 2001-08-16 | 2008-01-31 | Baxter Healthcare S.A. | Pulmonary delivery of spherical insulin microparticles |
| US7402318B2 (en) * | 2001-11-14 | 2008-07-22 | Novartis Ag | Medical devices having antimicrobial coatings thereon |
| US6926965B2 (en) * | 2002-09-11 | 2005-08-09 | Novartis Ag | LbL-coated medical device and method for making the same |
| US8728525B2 (en) * | 2004-05-12 | 2014-05-20 | Baxter International Inc. | Protein microspheres retaining pharmacokinetic and pharmacodynamic properties |
| ATE374627T1 (de) * | 2004-05-20 | 2007-10-15 | Boston Scient Ltd | Medizinische vorrichtungen und verfahren zu ihrer herstellung |
| US8133274B2 (en) * | 2004-06-18 | 2012-03-13 | Medennium, Inc. | Photochromic intraocular lenses and methods of making the same |
| EP1814490A2 (en) * | 2004-10-06 | 2007-08-08 | Cook Incorporated | Medical device with bioactive agent |
| US7767251B2 (en) * | 2005-03-16 | 2010-08-03 | Shiping Wang | Repellent elastomeric article |
| AU2006241145B2 (en) * | 2005-04-27 | 2011-04-28 | Baxter Healthcare S. A. | Surface-modified microparticles and methods of forming and using the same |
| US20070067882A1 (en) * | 2005-09-21 | 2007-03-22 | Liliana Atanasoska | Internal medical devices having polyelectrolyte-containing extruded regions |
| WO2007038964A1 (en) | 2005-10-05 | 2007-04-12 | Sca Hygiene Products Ab | Absorbent article comprising hydrophilic and hydrophobic regions |
| JP2009509702A (ja) * | 2005-10-05 | 2009-03-12 | エスセーアー・ハイジーン・プロダクツ・アーベー | 活性剤を含む薄膜を備えた吸収性物品 |
| US20080300560A1 (en) * | 2005-11-30 | 2008-12-04 | Sca Hygiene Products Ab | Absorbent Article |
| WO2007073246A1 (en) * | 2005-12-20 | 2007-06-28 | Sca Hygiene Products Ab | New article |
| US8840660B2 (en) | 2006-01-05 | 2014-09-23 | Boston Scientific Scimed, Inc. | Bioerodible endoprostheses and methods of making the same |
| US8044112B2 (en) | 2006-03-30 | 2011-10-25 | Novartis Ag | Method for applying a coating onto a silicone hydrogel lens |
| US20080094573A1 (en) * | 2006-04-04 | 2008-04-24 | Vermette Patrick | Surface-modified materials, such as contact lenses, methods and kits for their preparation, and uses thereof |
| US20070281031A1 (en) * | 2006-06-01 | 2007-12-06 | Guohan Yang | Microparticles and methods for production thereof |
| US7858000B2 (en) * | 2006-06-08 | 2010-12-28 | Novartis Ag | Method of making silicone hydrogel contact lenses |
| ATE470681T1 (de) | 2006-07-12 | 2010-06-15 | Novartis Ag | Aktinisch vernetzbare copolymere zur herstellung von kontaktlinsen |
| EP2056883B1 (en) * | 2006-08-04 | 2021-09-22 | Baxter International Inc. | Microsphere-based composition for preventing and/or reversing new-onset autoimmune diabetes |
| EP2399616A1 (en) | 2006-09-15 | 2011-12-28 | Boston Scientific Scimed, Inc. | Bioerodible endoprosthesis with biostable inorganic layers |
| JP2010505882A (ja) * | 2006-10-06 | 2010-02-25 | バクスター・インターナショナル・インコーポレイテッド | 表面改質微粒子を含むマイクロエンカプセルならびに、その形成および使用の方法 |
| EP2089069B1 (en) | 2006-10-30 | 2016-01-27 | Novartis AG | Method for applying a coating onto a silicone hydrogel lens |
| AR064286A1 (es) * | 2006-12-13 | 2009-03-25 | Quiceno Gomez Alexandra Lorena | Produccion de dispositivos oftalmicos basados en la polimerizacion por crecimiento escalonado fotoinducida |
| EP2101838B1 (en) * | 2006-12-21 | 2010-12-01 | Novartis AG | Process for the coating of contact lenses |
| US8080055B2 (en) | 2006-12-28 | 2011-12-20 | Boston Scientific Scimed, Inc. | Bioerodible endoprostheses and methods of making the same |
| ATE532089T1 (de) * | 2007-02-09 | 2011-11-15 | Novartis Ag | Vernetzbare polyionische beschichtungen für kontaktlinsen |
| US20080203592A1 (en) * | 2007-02-26 | 2008-08-28 | Yongxing Qiu | Method for imparting hydrogel contact lenses with desired properties |
| TW200840554A (en) * | 2007-02-28 | 2008-10-16 | Alcon Inc | Coated medical implants and lenses |
| CA2680524C (en) | 2007-03-22 | 2016-05-17 | Novartis Ag | Silicone-containing prepolymers with dangling hydrophilic polymer chains |
| RU2462361C2 (ru) | 2007-03-22 | 2012-09-27 | Новартис Аг | Форполимеры с подвешенными полисилоксансодержащими полимерными цепями |
| DE102007024642A1 (de) * | 2007-05-24 | 2008-11-27 | Eyesense Ag | Hydrogel-Implantat für Sensorik von Metaboliten am Auge |
| US20080311177A1 (en) | 2007-06-14 | 2008-12-18 | Massachusetts Institute Of Technology | Self Assembled Films for Protein and Drug Delivery Applications |
| US8052745B2 (en) | 2007-09-13 | 2011-11-08 | Boston Scientific Scimed, Inc. | Endoprosthesis |
| US8044111B2 (en) | 2007-11-30 | 2011-10-25 | Novartis Ag | Actinically-crosslinkable silicone-containing block copolymers |
| WO2009076159A2 (en) * | 2007-12-12 | 2009-06-18 | Emembrane, Inc. | Hydrophilic coating of polymeric substrates |
| US20090155519A1 (en) * | 2007-12-12 | 2009-06-18 | Emembrane Inc. | Hydrophilic Coating Of polymeric Substrates |
| US20090155595A1 (en) * | 2007-12-12 | 2009-06-18 | Emembrane Inc. | Polymeric Composites with a Hydrophilic Coating |
| RU2488863C2 (ru) | 2007-12-20 | 2013-07-27 | Новартис Аг | Способ изготовления контактных линз |
| EP2234798B1 (en) * | 2008-01-23 | 2012-03-28 | Novartis AG | Method for coating silicone hydrogels |
| US8460743B2 (en) * | 2008-03-18 | 2013-06-11 | Novartis Ag | Coating process for ophthalmic lenses |
| US20110084019A1 (en) * | 2008-03-26 | 2011-04-14 | Kaneka Corporation | Antithrombogenic surface |
| US20090244479A1 (en) * | 2008-03-31 | 2009-10-01 | Diana Zanini | Tinted silicone ophthalmic devices, processes and polymers used in the preparation of same |
| US8236046B2 (en) | 2008-06-10 | 2012-08-07 | Boston Scientific Scimed, Inc. | Bioerodible endoprosthesis |
| WO2010011493A1 (en) | 2008-07-21 | 2010-01-28 | Novartis Ag | Silicone-containing polymeric materals with hydrolyzable groups |
| EP2307189B1 (en) | 2008-07-21 | 2014-06-04 | Novartis AG | Silicone hydrogel contact lenses with convertible comfort agents |
| US8323685B2 (en) * | 2008-08-20 | 2012-12-04 | Baxter International Inc. | Methods of processing compositions containing microparticles |
| US20100047292A1 (en) * | 2008-08-20 | 2010-02-25 | Baxter International Inc. | Methods of processing microparticles and compositions produced thereby |
| US8367427B2 (en) * | 2008-08-20 | 2013-02-05 | Baxter International Inc. | Methods of processing compositions containing microparticles |
| US8323615B2 (en) * | 2008-08-20 | 2012-12-04 | Baxter International Inc. | Methods of processing multi-phasic dispersions |
| US8382824B2 (en) | 2008-10-03 | 2013-02-26 | Boston Scientific Scimed, Inc. | Medical implant having NANO-crystal grains with barrier layers of metal nitrides or fluorides |
| CA2739102C (en) * | 2008-11-13 | 2016-06-21 | Novartis Ag | Silicone hydrogel materials with chemically bound wetting agents |
| NZ591769A (en) * | 2008-11-13 | 2012-06-29 | Novartis Ag | Polysiloxane copolymers with terminal hydrophilic polymer chains |
| TWI506333B (zh) | 2008-12-05 | 2015-11-01 | Novartis Ag | 用以傳遞疏水性舒適劑之眼用裝置及其製造方法 |
| NZ592674A (en) * | 2008-12-18 | 2012-08-31 | Novartis Ag | Method for making silicone hydrogel contact lenses |
| US8163358B2 (en) * | 2009-02-18 | 2012-04-24 | Synergeyes, Inc. | Surface modification of contact lenses |
| US8267992B2 (en) | 2009-03-02 | 2012-09-18 | Boston Scientific Scimed, Inc. | Self-buffering medical implants |
| CA2771138C (en) | 2009-09-15 | 2016-01-19 | Novartis Ag | Prepolymers suitable for making ultra-violet absorbing contact lenses |
| US20110064936A1 (en) * | 2009-09-17 | 2011-03-17 | Massachusetts Institute Of Technology | Method of Asymmetrically Functionalizing Porous Materials |
| HUE10768474T2 (hu) * | 2009-10-16 | 2017-04-28 | Novartis Ag | Kontaktlencsék merítõfürdõkön át történõ szállítására szolgáló készülék és eljárás |
| TWI483996B (zh) * | 2009-12-08 | 2015-05-11 | Novartis Ag | 具有共價貼合塗層之聚矽氧水凝膠鏡片 |
| US9046644B2 (en) | 2010-02-16 | 2015-06-02 | Toray Industries, Inc. | Low water content soft lens for eye, and method for producing the same |
| WO2011119573A1 (en) | 2010-03-23 | 2011-09-29 | Boston Scientific Scimed, Inc. | Surface treated bioerodible metal endoprostheses |
| WO2011140136A2 (en) * | 2010-05-03 | 2011-11-10 | Massachusetts Institute Of Technology | Drug delivery coating and devices |
| US9522980B2 (en) | 2010-05-06 | 2016-12-20 | Johnson & Johnson Vision Care, Inc. | Non-reactive, hydrophilic polymers having terminal siloxanes and methods for making and using the same |
| US10231721B2 (en) | 2010-06-24 | 2019-03-19 | St. Croix Surgical Systems, Llc | Failsafe percutaneous wound barrier |
| US8557940B2 (en) | 2010-07-30 | 2013-10-15 | Novartis Ag | Amphiphilic polysiloxane prepolymers and uses thereof |
| TWI599813B (zh) | 2010-07-30 | 2017-09-21 | 諾華公司 | 水合隱形鏡片 |
| WO2012047964A1 (en) | 2010-10-06 | 2012-04-12 | Novartis Ag | Chain-extended polysiloxane crosslinkers with dangling hydrophilic polymer chains |
| WO2012047961A1 (en) | 2010-10-06 | 2012-04-12 | Novartis Ag | Polymerizable chain-extended polysiloxanes with pendant hydrophilic groups |
| WO2012047969A1 (en) | 2010-10-06 | 2012-04-12 | Novartis Ag | Water-processable silicone-containing prepolymers and uses thereof |
| US9170349B2 (en) | 2011-05-04 | 2015-10-27 | Johnson & Johnson Vision Care, Inc. | Medical devices having homogeneous charge density and methods for making same |
| WO2012153682A1 (ja) * | 2011-05-12 | 2012-11-15 | 日立化成工業株式会社 | 基材付き薄膜フィルム及びその製造方法 |
| US9377562B2 (en) | 2011-08-17 | 2016-06-28 | Toray Industries, Inc. | Medical device, and method for producing same |
| JP6070193B2 (ja) | 2011-08-17 | 2017-02-01 | 東レ株式会社 | 医療デバイスおよびその製造方法 |
| WO2013024801A1 (ja) | 2011-08-17 | 2013-02-21 | 東レ株式会社 | 医療デバイスおよびその製造方法 |
| CN105717662B (zh) | 2011-08-17 | 2020-05-19 | 东丽株式会社 | 医疗设备、涂布溶液的组合和医疗设备的制造方法 |
| JP6236782B2 (ja) | 2011-08-17 | 2017-11-29 | 東レ株式会社 | 低含水性軟質眼用レンズおよびその製造方法 |
| SG11201400228WA (en) | 2011-10-12 | 2014-05-29 | Novartis Ag | Method for making uv-absorbing ophthalmic lenses by coating |
| US9624377B2 (en) | 2011-10-27 | 2017-04-18 | Baker Hughes Incorporated | Methods of using sand composites to control dust |
| US9637671B2 (en) | 2011-10-27 | 2017-05-02 | Baker Hughes Incorporated | Method of suppressing the generation of dust from sand |
| US9328590B2 (en) | 2011-10-27 | 2016-05-03 | Baker Hughes Incorporated | Well treatment operations using a treatment agent coated with alternating layers of polyionic material |
| US9644140B2 (en) | 2011-10-27 | 2017-05-09 | Baker Hughes Incorporated | Method of reducing dust with particulates coated with a polycationic polymer |
| US9168565B2 (en) | 2011-10-27 | 2015-10-27 | Baker Hughes Incorporated | Method of reducing dust with self-assembly composites |
| US9505184B2 (en) | 2011-11-15 | 2016-11-29 | Novartis Ag | Silicone hydrogel lens with a crosslinked hydrophilic coating |
| EP2793851B1 (en) | 2011-12-21 | 2016-04-27 | Novartis AG | Contact lenses containing carotenoid and method for making same |
| WO2013163234A1 (en) | 2012-04-23 | 2013-10-31 | Massachusetts Institute Of Technology | Stable layer-by-layer coated particles |
| US9244196B2 (en) | 2012-05-25 | 2016-01-26 | Johnson & Johnson Vision Care, Inc. | Polymers and nanogel materials and methods for making and using the same |
| US10073192B2 (en) | 2012-05-25 | 2018-09-11 | Johnson & Johnson Vision Care, Inc. | Polymers and nanogel materials and methods for making and using the same |
| JP2015526745A (ja) | 2012-05-25 | 2015-09-10 | ジョンソン・アンド・ジョンソン・ビジョン・ケア・インコーポレイテッドＪｏｈｎｓｏｎ ＆ Ｊｏｈｎｓｏｎ Ｖｉｓｉｏｎ Ｃａｒｅ， Ｉｎｃ． | 水溶性ｎ−（２ヒドロキシアルキル）（メタ）アクリルアミドポリマー又はコポリマーを含むコンタクトレンズ |
| WO2013188274A2 (en) | 2012-06-14 | 2013-12-19 | Novartis Ag | Azetidinium-containing copolymers and uses thereof |
| US9395468B2 (en) | 2012-08-27 | 2016-07-19 | Ocular Dynamics, Llc | Contact lens with a hydrophilic layer |
| SG11201504592YA (en) * | 2012-12-11 | 2015-07-30 | Novartis Ag | Method for applying a coating onto a silicone hydrogel lens |
| MY172901A (en) | 2012-12-17 | 2019-12-13 | Alcon Inc | Method for making improved uv-absorbing ophthalmic lenses |
| WO2014134029A1 (en) | 2013-02-26 | 2014-09-04 | Massachusetts Institute Of Technology | Nucleic acid particles, methods and use thereof |
| WO2014150074A1 (en) | 2013-03-15 | 2014-09-25 | Massachusetts Institute Of Technology | Compositions and methods for nucleic acid delivery |
| US9950483B2 (en) | 2013-05-29 | 2018-04-24 | Novartis Ag | Method for determining the surface concentration of carboxyl groups on a lens |
| US9568645B2 (en) | 2013-09-30 | 2017-02-14 | Novartis Ag | Silicone hydrogel lenses with relatively-long thermal stability |
| US9315669B2 (en) | 2013-09-30 | 2016-04-19 | Novartis Ag | Method for making UV-absorbing ophthalmic lenses |
| SG11201602210WA (en) | 2013-10-31 | 2016-05-30 | Novartis Ag | Method for producing ophthalmic lenses |
| CA2930552C (en) | 2013-11-15 | 2022-12-13 | Ocular Dynamics, Llc | Contact lens with a hydrophilic layer |
| MY183117A (en) | 2013-12-13 | 2021-02-15 | Alcon Inc | Method for making contact lenses |
| US9708087B2 (en) | 2013-12-17 | 2017-07-18 | Novartis Ag | Silicone hydrogel lens with a crosslinked hydrophilic coating |
| US9975066B2 (en) * | 2014-05-27 | 2018-05-22 | Artificial Cell Technologies, Inc. | Automated layer by layer construction of multilayer coated cores by TFF |
| BR112017003447B1 (pt) | 2014-08-26 | 2021-10-26 | Alcon Inc | Copolímero de poli(oxazolina-co-etilenoimina)-epicloridrina, material polimérico hidrofílico reticulável termicamente e solúvel em água, e métodos para produzir lentes de contato revestidas |
| US11002884B2 (en) | 2014-08-26 | 2021-05-11 | Alcon Inc. | Method for applying stable coating on silicone hydrogel contact lenses |
| CA2970010A1 (en) | 2014-12-09 | 2016-06-16 | Karen Havenstrite | Medical device coating with a biocompatible layer |
| US9453949B2 (en) * | 2014-12-15 | 2016-09-27 | Eastman Chemical Company | Electromagnetic energy-absorbing optical product and method for making |
| US10723842B2 (en) | 2015-03-11 | 2020-07-28 | University Of Florida Research Foundation, Inc. | Mesh size control of lubrication in gemini hydrogels |
| US9810812B2 (en) | 2015-09-04 | 2017-11-07 | Novartis Ag | Method for producing contact lenses with durable lubricious coatings thereon |
| MY186090A (en) | 2015-12-03 | 2021-06-21 | Alcon Inc | Contact lens packaging solutions |
| EP3391101B1 (en) | 2015-12-15 | 2020-07-08 | Alcon Inc. | Method for applying stable coating on silicone hydrogel contact lenses |
| EP3390026A1 (en) | 2015-12-15 | 2018-10-24 | Novartis AG | Method for producing contact lenses with a lubricious surface |
| TWI606850B (zh) * | 2015-12-22 | 2017-12-01 | 美樺興業股份有限公司 | 人工水晶體以及其製作方法 |
| TWI691409B (zh) * | 2016-04-21 | 2020-04-21 | 美商伊士曼化學公司 | 吸收電磁能之光學製品 |
| JP6718608B2 (ja) * | 2016-05-25 | 2020-07-08 | 国立大学法人愛媛大学 | 眼表面・眼瞼摩擦係数測定装置および眼表面・眼瞼摩擦係数評価方法 |
| WO2018021458A1 (ja) * | 2016-07-28 | 2018-02-01 | 東レ株式会社 | 医療デバイス、医療デバイスの製造方法 |
| MY189895A (en) | 2016-09-20 | 2022-03-18 | Novartis Ag | Process for producing contact lenses with durable lubricious coatings thereon |
| US10718960B2 (en) | 2016-10-31 | 2020-07-21 | Alcon Inc. | Method for producing contact lenses with wearing comfort |
| TW201823501A (zh) | 2016-11-16 | 2018-07-01 | 美商陶氏全球科技有限責任公司 | 用於製造膜上之薄塗層之方法 |
| AU2018279285B2 (en) | 2017-06-07 | 2020-12-17 | Alcon Inc. | Silicone hydrogel contact lenses |
| EP4481478A3 (en) | 2017-06-07 | 2025-03-26 | Alcon Inc. | Silicone hydrogel contact lenses |
| US10809181B2 (en) * | 2017-08-24 | 2020-10-20 | Alcon Inc. | Method and apparatus for determining a coefficient of friction at a test site on a surface of a contact lens |
| US10338287B2 (en) | 2017-08-29 | 2019-07-02 | Southwall Technologies Inc. | Infrared-rejecting optical products having pigmented coatings |
| US11747532B2 (en) | 2017-09-15 | 2023-09-05 | Southwall Technologies Inc. | Laminated optical products and methods of making them |
| US11419947B2 (en) | 2017-10-30 | 2022-08-23 | Massachusetts Institute Of Technology | Layer-by-layer nanoparticles for cytokine therapy in cancer treatment |
| KR102735112B1 (ko) | 2017-12-13 | 2024-11-28 | 알콘 인코포레이티드 | 한 주 및 한 달 착용용 워터 그래디언트 콘택트 렌즈 |
| CN108451931B (zh) * | 2018-04-04 | 2021-04-30 | 华侨大学 | 一种pah/f聚电解质复合物纳米载体及其制备方法 |
| US10613261B2 (en) | 2018-04-09 | 2020-04-07 | Southwall Technologies Inc. | Selective light-blocking optical products having a neutral reflection |
| US10627555B2 (en) | 2018-04-09 | 2020-04-21 | Southwall Technologies Inc. | Selective light-blocking optical products having a neutral reflection |
| DE102018211526A1 (de) * | 2018-07-11 | 2020-01-16 | Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. | Beschichtung für implantierbare medizinische Geräte, Verfahren zu deren Herstellung sowie implantierbares medizinisches Gerät |
| EP3934623A4 (en) * | 2019-03-08 | 2022-11-23 | University of Pittsburgh - Of the Commonwealth System of Higher Education | MULTI-LAYER DRUG DELIVERY COATING FOR CONTACT LENSES |
| EP3975841A1 (en) | 2019-05-30 | 2022-04-06 | Massachusetts Institute of Technology | Peptide nucleic acid functionalized hydrogel microneedles for sampling and detection of interstitial fluid nucleic acids |
| JP7564197B2 (ja) | 2019-11-04 | 2024-10-08 | アルコン インク． | 異なる柔軟性を有する表面を有するコンタクトレンズ |
| EP4369081B1 (en) | 2019-12-16 | 2025-06-25 | Alcon Inc. | Method for producing an ophthalmic product |
| TWI859401B (zh) | 2020-01-27 | 2024-10-21 | 新加坡商科萊博新加坡私人有限公司 | 光化可交聯的聚矽氧烷－聚甘油嵌段共聚物及其製造和使用方法 |
| TWI785630B (zh) | 2020-06-02 | 2022-12-01 | 瑞士商愛爾康公司 | 光致變色矽酮水凝膠接觸鏡片及可聚合組合物及製造彼等之方法 |
| US12358247B2 (en) | 2020-07-28 | 2025-07-15 | Alcon Inc. | Contact lenses with softer lens surfaces |
| EP4237232B1 (en) | 2020-10-28 | 2024-11-27 | Alcon Inc. | Method for making photochromic contact lenses |
| WO2022097048A1 (en) | 2020-11-04 | 2022-05-12 | Alcon Inc. | Method for making photochromic contact lenses |
| WO2022097049A1 (en) | 2020-11-04 | 2022-05-12 | Alcon Inc. | Method for making photochromic contact lenses |
| WO2022189940A1 (en) | 2021-03-08 | 2022-09-15 | Alcon Inc. | Method for making photofunctional contact lenses |
| US11833771B2 (en) | 2021-04-01 | 2023-12-05 | Alcon Inc. | Method for making photochromic contact lenses |
| EP4448715A1 (en) | 2021-12-17 | 2024-10-23 | Cell2Bio AB | Surface coating for spheroid growth |
| TW202406726A (zh) | 2022-04-28 | 2024-02-16 | 瑞士商愛爾康公司 | 用於製造ｕｖ吸收性和ｈｅｖｌ吸收性眼科鏡片之方法 |
| TW202402513A (zh) | 2022-04-29 | 2024-01-16 | 瑞士商愛爾康公司 | 用於製造矽酮水凝膠接觸鏡片之方法 |
| US20240092043A1 (en) | 2022-08-17 | 2024-03-21 | Alcon Inc. | Contact lens with a hydrogel coating thereon |
| US20250361400A1 (en) | 2024-05-22 | 2025-11-27 | Alcon Inc. | Reactive hevl-absorbing dyes |
| WO2025243219A1 (en) | 2024-05-22 | 2025-11-27 | Alcon Inc. | Reactive dyes and their use in contact lenses |
| WO2025243218A1 (en) | 2024-05-22 | 2025-11-27 | Alcon Inc. | Method for making centrally colored contact lenses |
| US12225906B1 (en) * | 2024-09-26 | 2025-02-18 | Terry Earl Brady | Pathogenic affinity pathway of infectious or parasitic organisms for nanogram and picogram dosimetry prophylaxis or cure |
Family Cites Families (30)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4168112A (en) * | 1978-01-05 | 1979-09-18 | Polymer Technology Corporation | Contact lens with a hydrophilic, polyelectrolyte complex coating and method for forming same |
| DE3170785D1 (en) | 1980-01-10 | 1985-07-11 | Coopervision Inc | Cross-linked polymers for contact lenses |
| GB2102070A (en) | 1981-07-14 | 1983-01-26 | Anglo Netherland Engineering C | Assisted gas flow device |
| US4570629A (en) | 1982-03-17 | 1986-02-18 | University Of Illinois Foundation | Hydrophilic biopolymeric copolyelectrolytes, and biodegradable wound dressing comprising same |
| JPH01158412A (ja) * | 1986-12-26 | 1989-06-21 | Daicel Chem Ind Ltd | コンタクトレンズ用洗浄保存液 |
| US4941997A (en) * | 1987-07-13 | 1990-07-17 | Ciba-Geigy Corporation | Amphiphilic azo dyes and molecular aggregates thereof |
| EP0329613A3 (de) * | 1988-02-17 | 1991-06-05 | Ciba-Geigy Ag | Organische Materialien mit nichtlinearen optischen Eigenschaften |
| DE4026978A1 (de) * | 1990-08-25 | 1992-02-27 | Bayer Ag | Auf traegern angebrachte ein- oder mehrlagige schichtelemente und ihre herstellung |
| JP3166298B2 (ja) * | 1991-10-04 | 2001-05-14 | 株式会社ダイヘン | Ｇｍａ溶接のアーク長制御方法 |
| AU7061594A (en) | 1993-06-18 | 1995-01-17 | Polymer Technology Corporation | Contact lens solution containing peo and cationic cellulose |
| US5518767A (en) * | 1993-07-01 | 1996-05-21 | Massachusetts Institute Of Technology | Molecular self-assembly of electrically conductive polymers |
| GB9415926D0 (en) | 1994-08-04 | 1994-09-28 | Biocompatibles Ltd | New materials |
| US5529727A (en) * | 1994-07-20 | 1996-06-25 | Bausch & Lomb Incorporated | Method of treating contact lenses |
| US5760100B1 (en) | 1994-09-06 | 2000-11-14 | Ciba Vision Corp | Extended wear ophthalmic lens |
| US5700559A (en) | 1994-12-16 | 1997-12-23 | Advanced Surface Technology | Durable hydrophilic surface coatings |
| WO1996037241A1 (en) | 1995-05-25 | 1996-11-28 | Minnesota Mining And Manufacturing Company | Process for producing biocompatible surfaces |
| US6011082A (en) * | 1997-06-02 | 2000-01-04 | Pharmacia & Upjohn Ab | Process for the modification of elastomers with surface interpreting polymer networks and elastomers formed therefrom |
| PL341346A1 (en) * | 1998-01-09 | 2001-04-09 | Novartis Ag | Polymeric coatings |
| US6451871B1 (en) * | 1998-11-25 | 2002-09-17 | Novartis Ag | Methods of modifying surface characteristics |
| AR027348A1 (es) * | 2000-02-04 | 2003-03-26 | Novartis Ag | Proceso para recubrir una superficie |
| US6719929B2 (en) * | 2000-02-04 | 2004-04-13 | Novartis Ag | Method for modifying a surface |
| US6589665B2 (en) * | 2000-05-30 | 2003-07-08 | Novartis Ag | Coated articles |
| MXPA02011857A (es) | 2000-05-30 | 2003-04-10 | Novartis Ag | Articulos recubiertos. |
| JP4948740B2 (ja) * | 2000-08-24 | 2012-06-06 | ノバルティス アーゲー | 基材を表面改質する方法、及びそれから得られる改質された基材 |
| US6811805B2 (en) * | 2001-05-30 | 2004-11-02 | Novatis Ag | Method for applying a coating |
| US6815074B2 (en) | 2001-05-30 | 2004-11-09 | Novartis Ag | Polymeric materials for making contact lenses |
| US6858248B2 (en) * | 2001-05-30 | 2005-02-22 | Novartis Ag | Method for applying a coating to a medical device |
| US6827966B2 (en) * | 2001-05-30 | 2004-12-07 | Novartis Ag | Diffusion-controllable coatings on medical device |
| US7402318B2 (en) | 2001-11-14 | 2008-07-22 | Novartis Ag | Medical devices having antimicrobial coatings thereon |
| TWI255224B (en) * | 2002-01-09 | 2006-05-21 | Novartis Ag | Polymeric articles having a lubricious coating and method for making the same |
-
2003
- 2003-09-03 US US10/654,340 patent/US6896926B2/en not_active Expired - Lifetime
- 2003-09-10 AT AT03757817T patent/ATE353141T1/de not_active IP Right Cessation
- 2003-09-10 JP JP2004535481A patent/JP4551219B2/ja not_active Expired - Lifetime
- 2003-09-10 DE DE60311584T patent/DE60311584T2/de not_active Expired - Lifetime
- 2003-09-10 WO PCT/EP2003/010065 patent/WO2004025332A1/en not_active Ceased
- 2003-09-10 AU AU2003273851A patent/AU2003273851A1/en not_active Abandoned
- 2003-09-10 EP EP03757817A patent/EP1540381B1/en not_active Expired - Lifetime
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2022224717A1 (ja) | 2021-04-19 | 2022-10-27 | 国立研究開発法人物質・材料研究機構 | 軟質眼用レンズ及びその製造方法 |
Also Published As
| Publication number | Publication date |
|---|---|
| DE60311584D1 (de) | 2007-03-22 |
| AU2003273851A1 (en) | 2004-04-30 |
| JP2005538418A (ja) | 2005-12-15 |
| DE60311584T2 (de) | 2007-10-31 |
| US20040047979A1 (en) | 2004-03-11 |
| EP1540381B1 (en) | 2007-01-31 |
| US6896926B2 (en) | 2005-05-24 |
| WO2004025332A1 (en) | 2004-03-25 |
| ATE353141T1 (de) | 2007-02-15 |
| EP1540381A1 (en) | 2005-06-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP4551219B2 (ja) | ＬｂＬコーティングを医療用デバイスに適用する方法 | |
| JP4966495B2 (ja) | ＬｂＬコーティングされた医療用デバイスおよびそれを製造する方法 | |
| US6940580B2 (en) | Polymeric articles having a lubricious coating and method for making the same | |
| JP4681883B2 (ja) | 抗菌コーティングを有する医用デバイスの製造方法 | |
| US8147897B2 (en) | Cross-linkable polyionic coatings for medical devices | |
| JP4634603B2 (ja) | ポリマーのコーティング | |
| US20090288369A1 (en) | Biomedical device having improved surface characteristics | |
| MXPA02011857A (es) | Articulos recubiertos. | |
| JP2004507580A (ja) | 基材を表面改質する方法、及びそれから得られる改質された基材 | |
| CA2460027A1 (en) | Medical devices having antimicrobial coatings thereon |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20060829 |
|
| A524 | Written submission of copy of amendment under article 19 pct |
Free format text: JAPANESE INTERMEDIATE CODE: A524 Effective date: 20060829 |
|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20060829 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20090714 |
|
| A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20091009 |
|
| A602 | Written permission of extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A602 Effective date: 20091019 |
|
| A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20091102 |
|
| A602 | Written permission of extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A602 Effective date: 20091110 |
|
| A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20091214 |
|
| A602 | Written permission of extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A602 Effective date: 20091221 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20100114 |
|
| TRDD | Decision of grant or rejection written | ||
| A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20100615 |
|
| A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 |
|
| A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20100709 |
|
| R150 | Certificate of patent or registration of utility model |
Ref document number: 4551219 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20130716 Year of fee payment: 3 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| S111 | Request for change of ownership or part of ownership |
Free format text: JAPANESE INTERMEDIATE CODE: R313113 |
|
| S531 | Written request for registration of change of domicile |
Free format text: JAPANESE INTERMEDIATE CODE: R313531 |
|
| R350 | Written notification of registration of transfer |
Free format text: JAPANESE INTERMEDIATE CODE: R350 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| EXPY | Cancellation because of completion of term |